| 1 | [SID22409494] | Active | IC50 | 0.52521 | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput dose response assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1) [AID651672, Type: confirmatory] | PLIN1 gene product [Homo sapiens] [gi:223718203] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | IC50 | 0.52521 [uM] | | BioAssay | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput dose response assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1) | | AID | 651672 | | BioAssay type | confirmatory | | Target | PLIN1 gene product [Homo sapiens] [gi:223718203] | | PubMed | | | Data Table |  |
|
| 2 | [SID22409494] | Active | IC50 | 0.75047 | Luminescence-based biochemical high throughput dose response assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) [AID651677, Type: confirmatory] | ABHD5 gene product [Homo sapiens] [gi:31542303] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | IC50 | 0.75047 [uM] | | BioAssay | Luminescence-based biochemical high throughput dose response assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) | | AID | 651677 | | BioAssay type | confirmatory | | Target | ABHD5 gene product [Homo sapiens] [gi:31542303] | | PubMed | | | Data Table |  |
|
| 3 | [SID22409494] | Active | IC50 | 0.86219 | Luminescence-based biochemical high throughput dose response assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) produced in HEK293T cells [AID651733, Type: confirmatory] | ABHD5 gene product [Homo sapiens] [gi:31542303] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | IC50 | 0.86219 [uM] | | BioAssay | Luminescence-based biochemical high throughput dose response assay for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) produced in HEK293T cells | | AID | 651733 | | BioAssay type | confirmatory | | Target | ABHD5 gene product [Homo sapiens] [gi:31542303] | | PubMed | | | Data Table |  |
|
| 4 | [SID22409494] | Active | AC50 | 0.981 | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Cancer Stem Cells [AID449748, Type: confirmatory] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | AC50 | 0.981 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Cancer Stem Cells | | AID | 449748 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID22409494] | Active | AC50 | 1.541 | Dose Response HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP [AID463074, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | AC50 | 1.541 [uM] | | BioAssay | Dose Response HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP | | AID | 463074 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID22409494] | Active | IC50 | 1.556 | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput dose response assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization [AID651720, Type: confirmatory] | HNF4A gene product [Homo sapiens] [gi:31077205] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | IC50 | 1.556 [uM] | | BioAssay | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput dose response assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization | | AID | 651720 | | BioAssay type | confirmatory | | Target | HNF4A gene product [Homo sapiens] [gi:31077205] | | PubMed | | | Data Table |  |
|
| 7 | [SID22409494] | Active | IC50 | 1.556 | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput dose response assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization [AID651720, Type: confirmatory] | HNF4A gene product [Homo sapiens] [gi:31077205] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | IC50 | 1.556 [uM] | | BioAssay | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput dose response assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization | | AID | 651720 | | BioAssay type | confirmatory | | Target | HNF4A gene product [Homo sapiens] [gi:31077205] | | PubMed | | | Data Table |  |
|
| 8 | [SID22409494] | Active | IC50 | 1.556 | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput dose response assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization [AID651720, Type: confirmatory] | HNF4A gene product [Homo sapiens] [gi:31077205] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | IC50 | 1.556 [uM] | | BioAssay | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput dose response assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization | | AID | 651720 | | BioAssay type | confirmatory | | Target | HNF4A gene product [Homo sapiens] [gi:31077205] | | PubMed | | | Data Table |  |
|
| 9 | [SID22409494] | Active | Potency | 5.1735 | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. [AID624296, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 5.1735 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. | | AID | 624296 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 10 | [SID22409494] | Active | Potency | 5.3233 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 5.3233 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 11 | [SID22409494] | Active | Potency | 5.3233 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 5.3233 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 12 | [SID22409494] | Active | Potency | 5.3233 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 5.3233 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 13 | [SID22409494] | Active | Potency | 5.3233 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 5.3233 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 14 | [SID22409494] | Active | Potency | 7.9433 | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction [AID1461, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction | | AID | 1461 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 15 | [SID22409494] | Active | Potency | 7.9433 | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction [AID1461, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction | | AID | 1461 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 16 | [SID22409494] | Active | Potency | 8.9125 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID22409494] | Active | Potency | 10.3225 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 10.3225 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 18 | [SID22409494] | Active | Potency | 11.2202 | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity [AID2546, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2546 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 19 | [SID22409494] | Active | Potency | 11.5821 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID22409494] | Active | Potency | 14.581 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Cytotoxicity Assay [AID602204, Type: confirmatory] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 14.581 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Cytotoxicity Assay | | AID | 602204 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID22409494] | Active | CC50 | 16.49 | Vero 76 Cytoxicity Assay for VEEV Compounds [AID588719, Type: confirmatory] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | CC50 | 16.49 [uM] | | BioAssay | Vero 76 Cytoxicity Assay for VEEV Compounds | | AID | 588719 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID22409494] | Active | Potency | 17.7828 | qHTS of TDP-43 Inhibitors [AID652104, Type: confirmatory] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 17.7828 [uM] | | BioAssay | qHTS of TDP-43 Inhibitors | | AID | 652104 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID22409494] | Active | Potency | 18.3564 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 24 | [SID22409494] | Active | Potency | 18.3564 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 25 | [SID22409494] | Active | Potency | 18.3564 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 26 | [SID22409494] | Active | Potency | 18.3564 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 27 | [SID22409494] | Active | Potency | 22.3872 | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory] | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) | | AID | 894 | | BioAssay type | confirmatory | | Target | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] | | PubMed | | | Data Table |  |
|
| 28 | [SID22409494] | Active | Potency | 22.3872 | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory] | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) | | AID | 894 | | BioAssay type | confirmatory | | Target | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] | | PubMed | | | Data Table |  |
|
| 29 | [SID22409494] | Active | Potency | 22.3872 | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory] | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) | | AID | 894 | | BioAssay type | confirmatory | | Target | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] | | PubMed | | | Data Table |  |
|
| 30 | [SID22409494] | Active | Potency | 25.1189 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 31 | [SID22409494] | Active | Potency | 25.1189 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 32 | [SID22409494] | Active | Potency | 25.1189 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 33 | [SID22409494] | Active | Potency | 25.1189 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 34 | [SID22409494] | Active | Potency | 25.1189 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 35 | [SID22409494] | Active | Potency | 25.1189 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 36 | [SID22409494] | Active | Potency | 25.1189 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 37 | [SID22409494] | Active | Potency | 39.8107 | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 38 | [SID22409494] | Active | Potency | 39.8107 | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) [AID1490, Type: confirmatory] | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) | | AID | 1490 | | BioAssay type | confirmatory | | Target | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] | | PubMed | | | Data Table |  |
|
| 39 | [SID22409494] | Active | | | Single concentration confirmation of HIF-2a Inhibitors in a HIF-1a counterscreen in human MiAPaCa-2 Cells luciferase reporter assay [AID651589, Type: screening] | HIF1A gene product [Homo sapiens] [gi:4504385] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | BioAssay | Single concentration confirmation of HIF-2a Inhibitors in a HIF-1a counterscreen in human MiAPaCa-2 Cells luciferase reporter assay | | AID | 651589 | | BioAssay type | screening | | Target | HIF1A gene product [Homo sapiens] [gi:4504385] | | PubMed | | | Data Table |  |
|
| 40 | [SID22409494] | Active | | | Single concentration confirmation of HIF-2a Inhibitors in a HIF-1a counterscreen in human MiAPaCa-2 Cells luciferase reporter assay [AID651589, Type: screening] | HIF1A gene product [Homo sapiens] [gi:4504385] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | BioAssay | Single concentration confirmation of HIF-2a Inhibitors in a HIF-1a counterscreen in human MiAPaCa-2 Cells luciferase reporter assay | | AID | 651589 | | BioAssay type | screening | | Target | HIF1A gene product [Homo sapiens] [gi:4504385] | | PubMed | | | Data Table |  |
|
| 41 | [SID22409494] | Active | | | Single concentration confirmation of HIF-2a Inhibitors in a HIF-1a counterscreen in human MiAPaCa-2 Cells luciferase reporter assay [AID651589, Type: screening] | HIF1A gene product [Homo sapiens] [gi:4504385] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | BioAssay | Single concentration confirmation of HIF-2a Inhibitors in a HIF-1a counterscreen in human MiAPaCa-2 Cells luciferase reporter assay | | AID | 651589 | | BioAssay type | screening | | Target | HIF1A gene product [Homo sapiens] [gi:4504385] | | PubMed | | | Data Table |  |
|
| 42 | [SID22409494] | Active | | | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization [AID651674, Type: screening] | HNF4A gene product [Homo sapiens] [gi:31077205] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization | | AID | 651674 | | BioAssay type | screening | | Target | HNF4A gene product [Homo sapiens] [gi:31077205] | | PubMed | | | Data Table |  |
|
| 43 | [SID22409494] | Active | | | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization [AID651674, Type: screening] | HNF4A gene product [Homo sapiens] [gi:31077205] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization | | AID | 651674 | | BioAssay type | screening | | Target | HNF4A gene product [Homo sapiens] [gi:31077205] | | PubMed | | | Data Table |  |
|
| 44 | [SID22409494] | Active | | | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization [AID651674, Type: screening] | HNF4A gene product [Homo sapiens] [gi:31077205] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization | | AID | 651674 | | BioAssay type | screening | | Target | HNF4A gene product [Homo sapiens] [gi:31077205] | | PubMed | | | Data Table |  |
|
| 45 | [SID22409494] | Active | | | uHTS identification of HIF-2a Inhibitors in a luminesence assay [AID624352, Type: screening] | EPAS1 gene product [Homo sapiens] [gi:40254439] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | BioAssay | uHTS identification of HIF-2a Inhibitors in a luminesence assay | | AID | 624352 | | BioAssay type | screening | | Target | EPAS1 gene product [Homo sapiens] [gi:40254439] | | PubMed | | | Data Table |  |
|
| 46 | [SID22409494] | Active | | | uHTS identification of HIF-2a Inhibitors in a luminesence assay [AID624352, Type: screening] | EPAS1 gene product [Homo sapiens] [gi:40254439] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | BioAssay | uHTS identification of HIF-2a Inhibitors in a luminesence assay | | AID | 624352 | | BioAssay type | screening | | Target | EPAS1 gene product [Homo sapiens] [gi:40254439] | | PubMed | | | Data Table |  |
|
| 47 | [SID22409494] | Active | | | Single concentration confirmation of uHTS identification of HIF-2a Inhibitors in a luminesence assay [AID651580, Type: screening] | EPAS1 gene product [Homo sapiens] [gi:40254439] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS identification of HIF-2a Inhibitors in a luminesence assay | | AID | 651580 | | BioAssay type | screening | | Target | EPAS1 gene product [Homo sapiens] [gi:40254439] | | PubMed | | | Data Table |  |
|
| 48 | [SID22409494] | Active | | | Single concentration confirmation of uHTS identification of HIF-2a Inhibitors in a luminesence assay [AID651580, Type: screening] | EPAS1 gene product [Homo sapiens] [gi:40254439] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS identification of HIF-2a Inhibitors in a luminesence assay | | AID | 651580 | | BioAssay type | screening | | Target | EPAS1 gene product [Homo sapiens] [gi:40254439] | | PubMed | | | Data Table |  |
|
| 49 | [SID22409494] | Active | | | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity [AID488899, Type: screening] | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488899 | | BioAssay type | screening | | Target | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] | | PubMed | | | Data Table |  |
|
| 50 | [SID22409494] | Active | | | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity [AID488899, Type: screening] | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 22409494 | | CID | 6377798 | | Outcome | Active | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488899 | | BioAssay type | screening | | Target | Microphthalmia-associated transcription factor [Homo sapiens] [gi:40807040] | | PubMed | | | Data Table |  |
|